At high partial pressures oxygen appears to inhibit several tissue enzyme and coenzyme systems, some of which play vital roles in the process of inflammation.1" 12 Thus, one might postulate that oxygen at raised ambient pressure inhibits or modifies the inflammatory response of marginal tissue to anoxic injury by means as yet not completely understood.
Further investigation into the complex biologic actions of HPO is warranted to insure rational and effective clinical utilization in the management of peripheral vascular ischemia.
Conclusion
Hyperbaric oxygen was utilized in the management of 18 patients with chronically advanced occlusive arterial disease. All exhibited areas of potential or incipient gangrene, had undergone a prior lumbar sympathectomy, and angiographically revealed either diffuse or small vessel atherosclerotic involvement.
The treatment program consisted of daily 1-hour exposures to 100 per cent oxygen at three atmospheres absolute as clinically indicated. The majority of patients experienced temporary relief of rest pain and warming of the extremity, which gradually disappeared following decompression. However, over-all limb salvage and progression of the ischemic process was not significantly altered by highpressure oxygen therapy in this selected group of patients.
Microscopic review of marginal tissue adjacent to areas of ischemic necrosis disclosed a paucity of inflammatory findings regularly observed in nontreated extremities, suggesting an important relationship between hyperoxia and the cellular response to injury.
